[1]JournaloftheAmericanChemicalSociety,1943,vol.65,p.2467
[1]Patent:US2010/234340,2010,A1,.Locationinpatent:Page/Pagecolumn21
[2]BioorganicandMedicinalChemistry,2005,vol.13,#1,p.59-68
[3]Patent:US2004/204455,2004,A1,.Locationinpatent:Page/Pagecolumn21
[4]BioorganicandMedicinalChemistryLetters,1999,vol.9,#10,p.1403-1408
[5]Patent:US2008/275037,2008,A1,.Locationinpatent:Page/Pagecolumn33
[1]SyntheticCommunications,2018,vol.48,#11,p.1291-1298
[2]Chemistry-AEuropeanJournal,2017,vol.23,#57,p.14167-14172
[3]OrganicLetters,2016,vol.18,#24,p.6300-6303
[4]Patent:CN107162968,2017,A,.Locationinpatent:Paragraph0018;0019;0020-0023;0030-0050;0103-0106
[5]AdvancedSynthesisandCatalysis,2017,vol.359,#14,p.2358-2363
[6]OrganicLetters,2018,vol.20,#20,p.6436-6439
[1]BioorganicandMedicinalChemistry,2005,vol.13,#1,p.59-68
[2]Patent:US2004/204455,2004,A1,.Locationinpatent:Page/Pagecolumn17
[3]BioorganicandMedicinalChemistryLetters,1999,vol.9,#10,p.1403-1408
[4]Patent:US2008/275037,2008,A1,.Locationinpatent:Page/Pagecolumn33
[1]Patent:CN108409649,2018,A,.Locationinpatent:Paragraph0042;0043;0044
[2]Patent:US2010/234340,2010,A1,.Locationinpatent:Page/Pagecolumn21
[1]Experientia,1947,vol.3,p.28
[1]JournaloftheAmericanChemicalSociety,1943,vol.65,p.2467
[1]JournaloftheAmericanChemicalSociety,1943,vol.65,p.2467
[1]JournaloftheAmericanChemicalSociety,2019,vol.141,p.20424-20433
[2]AdvancedSynthesisandCatalysis,2017,vol.359,p.677-686
[3]Patent:US2432393,1943,
[4]Patent:US2442345,1945,
[1]JournaloftheAmericanChemicalSociety,1946,vol.68,p.426
Title: In vitro evaluation of 4-[3-(2-nitro-1-imidazolyl)-propylamino]-7-trifluoromethylquinoline hydrochloride (NLTQ-1), a new bioreductive agent as a hypoxia marker by 19F-magnetic resonance spectroscopy (19F-MRS).
Journal: In vivo (Athens, Greece) 20010101